Polymeric compositions
AssigneeBritish Technology Group Limited
InventorsRobert Charles Hider, Anthony Canas-Rodriguez
Life of this patent
Estimating the term…
Abstract
The invention provides a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups, the polymer having a minimum molecular weight of 10,000. The invention also extends to foodstuffs and pharmaceutical compositions comprising the physiologically acceptable polymer. Such foodstuffs and compositions are of value in controlling phosphate levels in the body.
Claims15
A pharmaceutical composition adapted for oral administration comprising a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups chemically bonded thereto through the terminal NH group and having a 3-dimensional network in which backbone polymer chains are cross-linked, the polymer having a minimum molecular weight of 10,000, in association with a pharmaceutically acceptable solid carrier.
A pharmaceutical composition adapted for oral administration comprising an effective unit dosage of a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups chemically bonded thereto through he terminal NH group, the polymer having a minimum molecular weight of 10,000, in association with a pharmaceutically acceptable diluent or carrier.
Dependencies are inferred from the claim text.